Read + Share
Kaneko GO, Igarashi D, Morita M, Tsubota S, et al. Real-world Outcomes of First-line Enfortumab Vedotin Plus Pembrolizumab in
Elderly Patients With Advanced Urothelial Carcinoma. Anticancer Res 2026;46:5715-5727.
PMID: 42823175
|
 |
|
Kaneko GO, Igarashi D, Morita M, Tsubota S, et al. Real-world Outcomes of First-line Enfortumab Vedotin Plus Pembrolizumab in
Elderly Patients With Advanced Urothelial Carcinoma. Anticancer Res 2026;46:5715-5727.
PMID: 42823175
|
|
|
|